Clinical Trial Update: Cabozantinib in High Grade Neuroendocrine Neoplasms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cabozantinib in patients with high-grade neuroendocrine neoplasms is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: High Grade Neuroendocrine Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING